Hepatic disease in dogs and cats encompasses a wide spectrum — from acute hepatotoxicity (often from drugs, toxins, or infectious agents) that may fully resolve with treatment, to chronic progressive conditions such as chronic hepatitis in dogs and cholangiohepatitis in cats that require lifelong management. The ACVIM Consensus Statement on canine chronic hepatitis notes that chronic hepatitis is characterised by hepatocellular apoptosis or necrosis, inflammatory infiltrate, and fibrosis — and that treatment is most successful when the primary cause is identified and eliminated, but that in most cases of canine chronic hepatitis, the cause remains unknown. A prospective study of 90 dogs with hepatobiliary disease found that clinical and laboratory monitoring over a 5-year period was significantly associated with survival outcomes — making follow-up not just supportive but prognostically determinative.
Why liver disease follow-up requires both laboratory monitoring and owner-reported signs
Liver disease has an insidious natural history. Clinical signs — lethargy, reduced appetite, weight loss, vomiting, jaundice, polyuria/polydipsia — often develop late, after significant hepatic mass loss has occurred. Elevated liver enzymes (ALT, ALP) may precede clinical signs by weeks to months in slowly progressing disease. This means the laboratory monitoring schedule is the primary early warning system, and owner-reported clinical signs are the secondary alert for progression between appointments.
For cats specifically, the combination of hepatic disease with concurrent pancreatitis and inflammatory bowel disease — “triaditis” — is a recognised syndrome that requires simultaneous management. A follow-up call that asks about GI signs (vomiting, diarrhoea, reduced appetite) in a cat with diagnosed hepatic disease may be capturing concurrent inflammatory intestinal disease rather than primary hepatic progression.
The medication complexity adds further follow-up requirements. Dogs with immune-mediated or idiopathic chronic hepatitis are often managed with prednisolone, sometimes combined with azathioprine or ciclosporin, with hepatic enzyme monitoring required to assess treatment response and drug toxicity. Cats with cholangiohepatitis may be on antibiotics, ursodiol, prednisolone, or cobalamin — each requiring its own monitoring parameter.
The liver disease follow-up timeline
| Timepoint | What to check | Red flags |
|---|---|---|
| 2–4 weeks post-diagnosis or treatment change | Owner-reported clinical signs — appetite, energy, weight, vomiting; early liver enzyme response to treatment; medications being given consistently; SAMe or milk thistle if prescribed | Worsening clinical signs despite treatment — consider diagnosis review or dose adjustment; jaundice developing |
| 6–8 weeks | Liver enzyme panel (ALT, ALP, GGT, bilirubin), bile acids, full biochemistry; clinical improvement assessed; medication compliance; weight | Rising enzymes despite treatment — reassess underlying cause; azotaemia developing if on NSAIDs or SAMe overdose |
| Every 3 months (chronic disease) | Full liver panel, bile acids, coagulation if indicated, weight, owner-reported signs; copper-restricted diet compliance if copper-associated hepatitis | Progressive enzyme elevation despite treatment — liver biopsy or repeat biopsy needed; clinical signs of hepatic encephalopathy |
| Every 6 months (stable) | Monitoring panel, weight, dietary compliance, medication review | Any clinical deterioration — accelerate monitoring |
What to ask owners during liver disease follow-up
- Has [pet name]‘s appetite improved, stayed the same, or declined since starting treatment?
- Is she maintaining her weight — has she been gaining or losing since the last visit?
- Have you noticed any vomiting or diarrhoea?
- Is there any yellowing of the gums, skin, or whites of the eyes — signs of jaundice?
- Is she drinking more water than normal?
- Is she alert and active, or more lethargic than you’d expect?
- Have you been giving all medications consistently — and at the correct doses?
- For dogs on special diets (low copper, low protein): have you been strict with the prescribed diet — no treats or table scraps?
- For cats on cobalamin injections: have you been giving these as directed?
- Do you have your blood test appointment booked?
Common liver disease follow-up mistakes clinics make
Not establishing a monitoring schedule at diagnosis. Owners who are not given a specific monitoring calendar — when is the next blood test, what does it check, what result would change the management — frequently defer monitoring until clinical signs are apparent. At that point, significant progression has occurred. A follow-up call that confirms “your next blood test is scheduled for [date], specifically to check ALT and ALP response to treatment” keeps monitoring on schedule.
Not asking about diet compliance in copper-associated hepatitis. Certain breeds — Bedlington Terriers, West Highland White Terriers, Dalmatians, Dobermans — are predisposed to copper-associated hepatitis where copper restriction is a primary management strategy. Owners on copper-restricted diets need specific follow-up on compliance, including identification of any high-copper foods (liver, shellfish) or treats that may be inadvertently included. A follow-up call that asks “have you given any liver treats or table food since starting the diet?” catches this.
Not monitoring for hepatic encephalopathy in advanced disease. Cats and dogs with significant hepatic dysfunction can develop hepatic encephalopathy — behavioural changes, ataxia, seizures, or altered consciousness — as ammonia and other neurotoxic compounds accumulate. A follow-up call that asks owners “has she seemed confused, disoriented, or had any unusual behavioural episodes?” catches HE in its early, more treatable stages.
How to automate liver disease follow-up without adding to your team’s workload
Nidana Loop schedules a 2-week owner-reported sign check and a 6–8 week blood test reminder automatically for hepatic disease cases. For chronic hepatitis patients, Loop schedules quarterly monitoring reminders and monthly clinical sign check-ins. The calls ask specifically about appetite, weight, jaundice signs, and medication compliance. The clinic sees flags for any case where clinical deterioration is reported between scheduled appointments.
See how Loop handles liver disease follow-up calls → Book a 20-minute demo
Related: Chronic kidney disease follow-up · Pancreatitis follow-up · IBD follow-up in dogs and cats